Omkar Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 10.50 Cr
as on 24-12-2024
- Paid Up Capital ₹ 10.08 Cr
as on 24-12-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.09 M
as on 24-12-2024
About Omkar Pharmachem
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532167.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 10.08 Cr.
The company has closed loans amounting to ₹1.09 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Omkar Pharmachem Limited India are Shivam Karotiya as COMPANY SECRETARY and Arun Kumar as Cfo. Mamta Pachauri, Janak Sharma, Bhawani Goyal, and One other member serve as directors at the Company.
- CIN/LLPIN
L93000GJ1995PLC025276
- Company No.
025276
- Stock Symbol
BSE : 532167
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Mar 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Omkar Pharmachem?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivam Karotiya | Company Secretary | 12-Aug-2024 | Current |
Bhawani Goyal  | Managing Director | 14-Feb-2020 | Current |
| Arun Kumar | CFO | 28-Dec-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamta Pachauri | Director | 29-Jun-2020 | Current |
| Janak Sharma | Director | 13-Feb-2016 | Current |
| Parminder Sharma | Director | 14-Nov-2003 | Current |
Financial Performance of Omkar Pharmachem.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Omkar Pharmachem?
Unlock access to Omkar Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pinnacle Capital Solutions Private LimitedActive 29 years 11 monthsShivam Karotiya is a mutual person
- Mishthi Foods And Beverages Private LimitedActive 13 years 8 months
Bhawani Goyal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Gujarat State Financial Co-Op Creation Date: 07 May 1995 | ₹1.09 M | Satisfied |
How Many Employees Work at Omkar Pharmachem?
Unlock and access historical data on people associated with Omkar Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omkar Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omkar Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
